Dompé Farmaceutici S.p.a
Clinical trials sponsored by Dompé Farmaceutici S.p.a, explained in plain language.
-
Drug trial for severe pneumonia stopped early after failing to show benefit
Disease control TerminatedThis study tested whether adding an oral drug called reparixin to standard hospital care could help patients with severe pneumonia, including from COVID-19. The goal was to see if it could prevent patients from dying or needing a breathing machine. The trial was stopped early aft…
Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Race to save insulin cells in new diabetes patients
Disease control TerminatedThis study tested whether an oral medication called ladarixin could help preserve the body's remaining insulin-producing cells in people recently diagnosed with type 1 diabetes. About 140 patients aged 14-45 took either ladarixin or a placebo for one year, with follow-up for anot…
Phase: PHASE2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Scientists probe the hidden pain of dry eye
Knowledge-focused TerminatedThis study aimed to understand how Sjögren's-related dry eye affects the nerves and pain sensitivity in the cornea (the clear front of the eye). Researchers observed 103 adult patients, measuring their eye sensitivity and tear production with standard clinical tools and a pain qu…
Sponsor: Dompé Farmaceutici S.p.A • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC